JPH07258234A - Production of 1,3,4-oxadiazole-2(3h)-thione compound - Google Patents

Production of 1,3,4-oxadiazole-2(3h)-thione compound

Info

Publication number
JPH07258234A
JPH07258234A JP6047180A JP4718094A JPH07258234A JP H07258234 A JPH07258234 A JP H07258234A JP 6047180 A JP6047180 A JP 6047180A JP 4718094 A JP4718094 A JP 4718094A JP H07258234 A JPH07258234 A JP H07258234A
Authority
JP
Japan
Prior art keywords
group
reaction
oxadiazole
compound
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP6047180A
Other languages
Japanese (ja)
Inventor
Toshio Isobe
敏男 磯部
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SHIRATORI SEIYAKU KK
Shiratori Pharmaceutical Co Ltd
Original Assignee
SHIRATORI SEIYAKU KK
Shiratori Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SHIRATORI SEIYAKU KK, Shiratori Pharmaceutical Co Ltd filed Critical SHIRATORI SEIYAKU KK
Priority to JP6047180A priority Critical patent/JPH07258234A/en
Publication of JPH07258234A publication Critical patent/JPH07258234A/en
Pending legal-status Critical Current

Links

Landscapes

  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PURPOSE:To obtain in high yield in a short time without H2S generation the subject compound useful as e.g. a medicine (synthetic intermediate) having anti-tuberculotic activity, analgesic activity, antipyretic activity, etc., by reaction of CS2 with a monoacylhydrazine compound followed by reaction of a specific haloiminium salt. CONSTITUTION:The objective compound is obtained by reaction of CS2 with a monoacylhydrazine compound such as a compound of formula I [R<3> is an organic group such as a (substituted) (cyclo)alkyl, (substituted) alkenyl, (substituted) aromatic group or (substituted) heterocyclic group] in the presence of a base such as triethylamine or NaOH followed by reaction of a haloiminium salt of formula II (R<1> and R<2> each is a lower alkyl; X is a halogen; (n) is 2 or 3).

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、1,3,4−オキサジ
アゾール−2(3H)−チオン類の製造法に関し、更に
詳細にはモノアシルヒドラジン類から安全かつ工業的に
有利に1,3,4−オキサジアゾール−2(3H)−チ
オン類を製造する方法に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a method for producing 1,3,4-oxadiazole-2 (3H) -thiones, and more specifically, to a safe and industrial advantage from monoacylhydrazines. , 3,4-Oxadiazole-2 (3H) -thiones.

【0002】[0002]

【従来の技術】1,3,4−オキサジアゾール−2(3
H)−チオン類は抗結核作用、鎮痛作用、解熱作用等の
作用を有するため医薬品や医薬品合成中間体として用い
られている。また、このものはテトラサイクリン合成に
おけるクロル化阻止剤としても用いられることもあり、
応用範囲の広い有用な化合物である〔Adv. Hetero. Che
m., ,183(1966)〕。
2. Description of the Related Art 1,3,4-oxadiazole-2 (3
Since H) -thiones have actions such as antituberculous action, analgesic action and antipyretic action, they are used as pharmaceuticals and pharmaceutical intermediates. In addition, this may also be used as a chlorination inhibitor in tetracycline synthesis,
It is a useful compound with a wide range of applications [Adv. Hetero. Che
m., 7 , 183 (1966)].

【0003】この1,3,4−オキサジアゾール−2
(3H)−チオン類の製造法としては、すでにいくつか
の方法が報告されている。このうち常法として用いられ
ている方法としては、モノアシルヒドラジン類に、アル
カリ存在下二硫化炭素を反応せしめ、次いでエタノール
中にて加熱閉環する方法が挙げられる。
This 1,3,4-oxadiazole-2
Several methods have already been reported as a method for producing (3H) -thiones. Among them, a method used as a conventional method is a method of reacting monoacylhydrazines with carbon disulfide in the presence of an alkali and then heating and ring-closing in ethanol.

【0004】[0004]

【発明が解決しようとする課題】しかしながら、上記の
加熱閉環による方法は一般に反応に長時間を要する。例
えば5−(2−フリル)−1,3,4−オキサジアゾー
ル−2(3H)−チオンの製造法〔Syntheses of Heter
ocyclic Compounds, Vol. 1,Consultants Bureau(195
9) p54〕ではエタノール中で30〜32時間加熱還流す
る必要があり、5−メチル−1,3,4−オキサジアゾ
ール−2(3H)−チオンの製造にあっては、1週間以
上加熱還流が必要であり、たとえジメチルスルホキシド
を加えて反応を加速したとしても36時間の加熱還流が
必要である〔J. Am. Chem. Soc.,78,4475(1956)〕。
However, the above-mentioned method by the heat ring closure generally requires a long time for the reaction. For example, a method for producing 5- (2-furyl) -1,3,4-oxadiazole-2 (3H) -thione [Syntheses of Heter
ocyclic Compounds, Vol. 1, Consultants Bureau (195
9) In p54], it is necessary to heat and reflux in ethanol for 30 to 32 hours. In the production of 5-methyl-1,3,4-oxadiazole-2 (3H) -thione, heating is performed for 1 week or more. Reflux is required, and even if dimethyl sulfoxide is added to accelerate the reaction, heating under reflux for 36 hours is required [J. Am. Chem. Soc., 78 , 4475 (1956)].

【0005】このような、反応に長時間を要する方法は
効率が悪く経済的でないばかりでなく、1,3,4−オ
キサジアゾール−2(3H)−チオン類のうち熱に不安
定なものについては適用できないか、収率が低いという
欠点があった。また、上記の方法では反応中に極めて毒
性の強い硫化水素ガスが発生するため、工業的規模の実
施に際しては細心の注意が必要であり、更にガス吸収塔
等の設備を備えなければならない。
Such a method requiring a long reaction time is not only inefficient and uneconomical, but also one of 1,3,4-oxadiazole-2 (3H) -thiones which is unstable to heat. However, there is a drawback that it is not applicable or the yield is low. Further, since hydrogen sulfide gas, which is extremely toxic, is generated during the reaction in the above-mentioned method, great care must be taken when carrying out on an industrial scale, and equipment such as a gas absorption tower must be provided.

【0006】従って、本発明の目的は短時間の反応で高
収率で、しかも硫化水素ガスを発生しない1,3,4−
オキサジアゾール−2(3H)−チオン類の製造法を提
供することにある。
Therefore, the object of the present invention is to produce 1,3,4-, which does not generate hydrogen sulfide gas with a high yield in a short reaction time.
An object of the present invention is to provide a method for producing oxadiazole-2 (3H) -thiones.

【0007】[0007]

【課題を解決するための手段】斯かる実状に鑑み本発明
者は鋭意研究を行なった結果、モノアシルヒドラジン類
に、塩基の存在下、二硫化炭素を反応させた後、後記一
般式(1)で表わされるハロイミニウム塩を反応せしめ
れば、硫化水素の発生がなく、短時間で高収率でしかも
中性かつ穏やかな条件で1,3,4−オキサジアゾール
−2(3H)−チオン類が製造できることを見出し本発
明を完成した。
In view of such circumstances, the present inventors have conducted diligent research, and as a result, after reacting monoacylhydrazines with carbon disulfide in the presence of a base, the following general formula (1) ) Is reacted with 1,3,4-oxadiazole-2 (3H) -thione in a high yield in a short time with a high yield and under neutral and mild conditions. The present invention has been completed by finding that a class can be produced.

【0008】本発明は、次の反応式によって示される。The present invention is shown by the following reaction formula.

【0009】[0009]

【化2】 [Chemical 2]

【0010】〔式中、R1 及びR2 は同一又は異なっ
て、それぞれ低級アルキル基を示し、Xはハロゲン原子
を示し、nは2又は3の整数を示し、R3 は有機基を示
し、B及びB′は塩基を示す〕
[In the formula, R 1 and R 2 are the same or different and each represents a lower alkyl group, X represents a halogen atom, n represents an integer of 2 or 3, and R 3 represents an organic group, B and B'represent a base]

【0011】すなわち本発明は、モノアシルヒドラジン
類(2)に、塩基(4)の存在下、二硫化炭素(3)を
反応せしめ、次いでハロイミニウム塩(1)を反応させ
ることを特徴とする1,3,4−オキサジアゾール−2
(3H)−チオン類の製造法を提供するものである。
That is, the present invention is characterized in that monoacylhydrazines (2) are reacted with carbon disulfide (3) in the presence of a base (4), and then with a haloiminium salt (1). , 3,4-oxadiazole-2
A method for producing (3H) -thiones is provided.

【0012】本発明に用いるハロイミニウム塩は一般式
(1)で表わされるものであり、式中、R1 及びR2
示される低級アルキル基としては、メチル基、エチル
基、n−プロピル基、イソプロピル基、n−ブチル基、
イソブチル基等の炭素数1〜6の直鎖又は分岐鎖のアル
キル基が挙げられる。また、Xで示されるハロゲン原子
としては、フッ素原子、塩素原子、臭素原子、ヨウ素原
子が挙げられるが、就中、塩素原子が特に好ましい。ハ
ロイミニウム塩(1)の好ましい具体例としては、2−
クロロ−1,3−ジメチルイミダゾリニウムクロライ
ド、2−クロロ−1,3−ジメチル−3,4,5,6−
テトラヒドロピリミジニウムクロライド等を挙げること
ができる。
The haloiminium salt used in the present invention is represented by the general formula (1). In the formula, the lower alkyl group represented by R 1 and R 2 includes a methyl group, an ethyl group, an n-propyl group, Isopropyl group, n-butyl group,
Examples thereof include linear or branched alkyl groups having 1 to 6 carbon atoms such as an isobutyl group. Further, examples of the halogen atom represented by X include a fluorine atom, a chlorine atom, a bromine atom and an iodine atom, and among them, a chlorine atom is particularly preferable. Specific preferred examples of the haloiminium salt (1) include 2-
Chloro-1,3-dimethylimidazolinium chloride, 2-chloro-1,3-dimethyl-3,4,5,6-
Examples thereof include tetrahydropyrimidinium chloride.

【0013】このハロイミニウム塩(1)は、例えば入
手容易な溶剤として知られている前記一般式(12)
This haloiminium salt (1) is represented by the above general formula (12) which is known as an easily available solvent.

【0014】[0014]

【化3】 [Chemical 3]

【0015】〔式中、R1、R2 及びnは前記と同じも
のを示す〕で表わされる化合物に、オキザリルハロゲニ
ド、三ハロゲン化リン、五ハロゲン化リン、オキシハロ
ゲン化リン、ホスゲン、トリクロロメチルクロロホルメ
ート等の自体公知のハロゲン化剤を反応せしめることに
より容易に得られる。この反応は、化合物(12)又は
ハロゲン化剤の何れか一方を四塩化炭素等の適当な溶媒
に溶かしておき、これに他方を少量ずつ添加し、更に室
温〜70℃で数時間〜十数時間反応させることによって
行なわれる。斯くして得られたハロイミニウム塩(1)
は単離することもできるが、単離することなく、その反
応液を本発明の反応に使用することもできる。
In the compound represented by the formula [wherein R 1 , R 2 and n are the same as defined above], oxalyl halogenide, phosphorus trihalide, phosphorus pentahalide, phosphorus oxyhalide, phosgene, It can be easily obtained by reacting a halogenating agent known per se such as trichloromethyl chloroformate. In this reaction, one of the compound (12) and the halogenating agent is dissolved in a suitable solvent such as carbon tetrachloride and the other is added little by little, and the mixture is further added at room temperature to 70 ° C. for several hours to several dozen. It is carried out by reacting for a time. The haloiminium salt (1) thus obtained
Can be isolated, but the reaction solution can also be used in the reaction of the present invention without isolation.

【0016】本発明方法の原料化合物であるモノアシル
ヒドラジン類は一般式(2)で表わされるものが好まし
いが、式中、R3 で示される基としては、置換基を有し
ていてもよいアルキル、シクロアルキル、アルケニル、
芳香族又は複素環式基が挙げられる。ここで、アルキル
基としては、直鎖又は分岐鎖の炭素数1〜20のアルキ
ル基、例えばメチル基、エチル基、プロピル基、ブチル
基、ペンチル基、ヘキシル基、ヘプチル基、オクチル
基、ノニル基、デシル基、ウンデシル基、ドデシル基、
トリデシル基、テトラデシル基、ペンタデシル基、ヘキ
サデシル基、ヘプタデシル基、オクタデシル基、ノナデ
シル基、エイコシル基等が例示される。アルケニル基と
しては、直鎖又は分岐鎖の炭素数2〜20のアルケニル
基、例えばビニル、プロペニル、アリル、ブテニル、ペ
ンテニル、ヘキセニル、ヘプテニル、オクテニル、ノネ
ニル、デセニル、ウンデセニル、ドデセニル、トリデセ
ニル、テトラデセニル、ペンタデセニル、ヘキサデセニ
ル、ヘプタデセニル、オクタデセニル、ノナデセニル、
エイコセニル基等が挙げられる。芳香族基としては、フ
ェニル基、トリル基、キシリル基、ビフェニリル、ナフ
チル等が挙げられる。また複素環式基としては、フリ
ル、フルフリル、チエニル、ピロリル、ピリジル、ピペ
リジノ、ピペリジル、キノリル基等が挙げられる。シク
ロアルキル基としては、シクロプロピル基、シクロブチ
ル基、シクロペンチル基、シクロヘキシル基等が挙げら
れる。
The monoacylhydrazines, which are the starting compounds for the method of the present invention, are preferably those represented by the general formula (2), but in the formula, the group represented by R 3 may have a substituent. Alkyl, cycloalkyl, alkenyl,
Included are aromatic or heterocyclic groups. Here, as the alkyl group, a linear or branched alkyl group having 1 to 20 carbon atoms, for example, methyl group, ethyl group, propyl group, butyl group, pentyl group, hexyl group, heptyl group, octyl group, nonyl group , Decyl group, undecyl group, dodecyl group,
Examples thereof include tridecyl group, tetradecyl group, pentadecyl group, hexadecyl group, heptadecyl group, octadecyl group, nonadecyl group and eicosyl group. The alkenyl group is a linear or branched alkenyl group having 2 to 20 carbon atoms, for example, vinyl, propenyl, allyl, butenyl, pentenyl, hexenyl, heptenyl, octenyl, nonenyl, decenyl, undecenyl, dodecenyl, tridecenyl, tetradecenyl, pentadecenyl. , Hexadecenyl, heptadecenyl, octadecenyl, nonadecenyl,
An eicosenyl group etc. are mentioned. Examples of the aromatic group include phenyl group, tolyl group, xylyl group, biphenylyl, naphthyl and the like. Examples of the heterocyclic group include furyl, furfuryl, thienyl, pyrrolyl, pyridyl, piperidino, piperidyl and quinolyl groups. Examples of the cycloalkyl group include a cyclopropyl group, a cyclobutyl group, a cyclopentyl group, a cyclohexyl group and the like.

【0017】また、これらの基の置換基は、特に限定さ
れず、水酸基、アミノ基、アルコキシ基、アルキルアミ
ノ基、アルコキシアミノ基、アルコキシカルボニルアミ
ノ基、アルキル基、アルケニル基、複素環式基等が挙げ
られ、更にエーテル結合や二重結合を含むものであって
もよい。
Substituents for these groups are not particularly limited, and include hydroxyl group, amino group, alkoxy group, alkylamino group, alkoxyamino group, alkoxycarbonylamino group, alkyl group, alkenyl group and heterocyclic group. And may further include an ether bond or a double bond.

【0018】一方、B又はB′で示される塩基は、同一
でも異なっていてもよく、有機塩基、無機塩基を問わな
い。塩基の具体例としては、例えばトリエチルアミン、
トリブチルアミン、N,N−ジメチルアニリン、ピリジ
ン等のアミン類;水酸化ナトリウム、炭酸カリウム、炭
酸カルシウム等が挙げられる。また、Xで示されるハロ
ゲン原子としては、フッ素原子、塩素原子、臭素原子、
ヨウ素原子が例示される。
On the other hand, the bases represented by B or B'may be the same or different and may be an organic base or an inorganic base. Specific examples of the base include, for example, triethylamine,
Amine such as tributylamine, N, N-dimethylaniline, pyridine; sodium hydroxide, potassium carbonate, calcium carbonate and the like. The halogen atom represented by X includes a fluorine atom, a chlorine atom, a bromine atom,
The iodine atom is exemplified.

【0019】本発明の製造法を実施するには、例えばモ
ノアシルヒドラジン類(2)1モルに対して二硫化炭素
(3)1モル、塩基(4)1モルを加えて反応させた
後、ハロイミニウム塩(1)約1モル及び塩基(7)を
約1モル加え室温付近で反応させればよい。なお、原料
の添加モル比は理論量であり、適宜増減できることはい
うまでもない。反応時間は2〜20時間程度で充分であ
る。
In order to carry out the production method of the present invention, for example, 1 mol of carbon disulfide (3) and 1 mol of base (4) are added to 1 mol of monoacylhydrazines (2) and reacted, About 1 mol of the haloiminium salt (1) and about 1 mol of the base (7) may be added and the reaction may be carried out near room temperature. Needless to say, the addition molar ratio of the raw materials is a theoretical amount and can be appropriately increased or decreased. A reaction time of about 2 to 20 hours is sufficient.

【0020】また、反応溶媒は、用いなくともよいが、
ジクロルメタン、ジクロルエタン等のハロゲン化炭化水
素、炭化水素、エーテル類、芳香族炭化水素等の反応に
関与しない溶媒を用いることもできる。更に反応装置は
工業的規模で行なう場合であっても、グラスライニング
等の特殊な反応釜でなく、通常のステンレス反応釜を用
いることができる。
The reaction solvent need not be used,
It is also possible to use a solvent that does not participate in the reaction, such as a halogenated hydrocarbon such as dichloromethane or dichloroethane, a hydrocarbon, an ether, or an aromatic hydrocarbon. Further, even when the reaction apparatus is carried out on an industrial scale, it is possible to use an ordinary stainless steel reaction kettle instead of a special reaction kettle such as glass lining.

【0021】[0021]

【発明の効果】本発明の製造法によれば、短時間の反応
で高収率で1,3,4−オキサジアゾール−2(3H)
−チオン類を製造することができる。また有毒な硫化水
素の発生がなく安全であり、反応が穏やかな条件で進む
ので特殊な装置類を必要としないため工業的に極めて有
利である。
According to the production method of the present invention, 1,3,4-oxadiazole-2 (3H) can be obtained in a high yield in a short reaction time.
-Thiones can be produced. In addition, it is safe without generation of toxic hydrogen sulfide, and since the reaction proceeds under mild conditions, no special equipment is required, which is extremely advantageous industrially.

【0022】[0022]

【実施例】以下に実施例を挙げて本発明を更に説明する
が、本発明はこれらによって何ら限定されるものではな
い。
The present invention will be further described below with reference to examples, but the present invention is not limited thereto.

【0023】実施例1 5−フェニル−1,3,4−オキサジアゾール−2(3
H)−チオンの製造:ベンゼン100ml及びアセトニト
リル150mlの混液中にベンゾヒドラジド5.0g(3
7mmol)及びトリエチルアミン5.6g(55mmol)を
加え、この中に二硫化炭素2.8g(37mmol)を滴下
した。終了後室温で5.5時間攪拌を続けた後、反応液
中に2−クロロ−1,3−ジメチルイミダゾリニウムク
ロライド7.4g(44mmol)の塩化メチレン25ml溶
液をゆっくりと滴下した。終了後室温で3時間攪拌を続
け、次いで、反応液に水を加え塩化メチレンで抽出し
た。抽出液を無水硫酸マグネシウムで乾燥し、減圧下溶
媒を留去して得た残渣をシリカゲルクロマトグラフィー
(溶媒 クロロホルム−メタノール)にて精製し標記化
合物を6.2g(収率95%)得た。
Example 1 5-Phenyl-1,3,4-oxadiazole-2 (3
Preparation of (H) -thione: 5.0 g (3) of benzohydrazide in a mixture of 100 ml of benzene and 150 ml of acetonitrile.
7 mmol) and 5.6 g (55 mmol) of triethylamine were added, and 2.8 g (37 mmol) of carbon disulfide was added dropwise thereto. After the completion of stirring, the mixture was stirred at room temperature for 5.5 hours, and then a solution of 2-chloro-1,3-dimethylimidazolinium chloride (7.4 g, 44 mmol) in methylene chloride (25 ml) was slowly added dropwise to the reaction mixture. After the completion, stirring was continued at room temperature for 3 hours, water was added to the reaction solution, and the mixture was extracted with methylene chloride. The extract was dried over anhydrous magnesium sulfate, the solvent was distilled off under reduced pressure, and the obtained residue was purified by silica gel chromatography (solvent chloroform-methanol) to obtain 6.2 g (yield 95%) of the title compound.

【0024】mp 218.9〜220.8℃ IRνmax KBrcm-1:3090, 1615, 1575, 1510, 1450, 135
0, 1185, 970
Mp 218.9-220.8 ° C IRν max KBr cm -1 : 3090, 1615, 1575, 1510, 1450, 135
0, 1185, 970

【0025】実施例2 5−(2−ピリジルメチル)−1,3,4−オキサジア
ゾール−2(3H)−チオンの製造:塩化メチレン10
0ml及びアセトニトリル100mlの混液中に2−ピリジ
ルアセトヒドラジド5.0g(33mmol)、トリエチル
アミン10.0g(99mmol)及び二硫化炭素2.5g
(33mmol)を加え、室温で4時間攪拌した後、反応液
中に2−クロロ−1,3−ジメチルイミダゾリニウムク
ロライド6.7g(40mmol)の塩化メチレン20ml溶
液をゆっくりと滴下した。終了後室温で3時間攪拌を続
け、次いで、減圧下溶媒を留去して得た残渣にアセトニ
トリルを加え不溶晶を濾別した。不溶晶はアセトニトリ
ルで洗浄し、洗液と濾液を合せて減圧下溶媒を留去し1
8.0gの残渣を得た。この残渣をシリカゲルクロマト
グラフィー(溶媒 クロロホルム−メタノール)にて精
製し標記化合物を3.7g(収率58%)得た。
Example 2 Preparation of 5- (2-pyridylmethyl) -1,3,4-oxadiazole-2 (3H) -thione: methylene chloride 10
5.0 g (33 mmol) of 2-pyridylacetohydrazide, 10.0 g (99 mmol) of triethylamine and 2.5 g of carbon disulfide in a mixture of 0 ml and 100 ml of acetonitrile.
(33 mmol) was added, and the mixture was stirred at room temperature for 4 hours, and then a solution of 2-chloro-1,3-dimethylimidazolinium chloride (6.7 g, 40 mmol) in methylene chloride (20 ml) was slowly added dropwise. After completion, stirring was continued at room temperature for 3 hours, then the solvent was distilled off under reduced pressure, and acetonitrile was added to the resulting residue to separate insoluble crystals by filtration. Insoluble crystals are washed with acetonitrile, the washing solution and the filtrate are combined, and the solvent is distilled off under reduced pressure.
8.0 g of residue was obtained. The residue was purified by silica gel chromatography (solvent chloroform-methanol) to obtain 3.7 g (yield 58%) of the title compound.

【0026】mp 163.0〜163.7℃ IRνmax KBrcm-1:2700, 2530, 1630, 1600, 1500, 136
0, 1320, 1145,1060
Mp 163.0 to 163.7 ° C. IRν max KBr cm −1 : 2700, 2530, 1630, 1600, 1500, 136
0, 1320, 1145, 1060

【0027】実施例3 5−(2−ヒドロキシ−1−プロピル)−1,3,4−
オキサジアゾール−2(3H)−チオンの製造:ジメチ
ルホルムアミド50ml中に、3−ヒドロキシブチロヒド
ラジド5.0g(42mmol)、トリエチルアミン12.
8g(127mmol)及び二硫化炭素3.2g(42mmo
l)を加え室温で3時間攪拌した。次いで、反応液中に
2−クロロ−1,3−ジメチルイミダゾリニウムクロラ
イド8.6g(51mmol)の塩化メチレン30ml溶液を
水冷下ゆっくりと滴下し、終了後室温で更に3時間攪拌
を続けた後、減圧下溶媒を留去して残渣を得た。この残
渣にアセトンを加え不溶晶を濾別し、不溶晶はアセトン
で洗浄し、濾液と洗液を合せて減圧下溶媒を留去し、赤
色油状物23.3gを得た。この油状物をシリカゲルク
ロマトグラフィー(溶媒 クロロホルム−メタノール)
にて精製し、標記化合物を6.3g(収率93%)得
た。
Example 3 5- (2-hydroxy-1-propyl) -1,3,4-
Preparation of oxadiazole-2 (3H) -thione: 5.0 g (42 mmol) of 3-hydroxybutyrohydrazide, 12.3 of triethylamine in 50 ml of dimethylformamide.
8 g (127 mmol) and 3.2 g of carbon disulfide (42 mmo
l) was added and the mixture was stirred at room temperature for 3 hours. Then, a solution of 8.6 g (51 mmol) of 2-chloro-1,3-dimethylimidazolinium chloride in 30 ml of methylene chloride was slowly added dropwise to the reaction mixture under water cooling, and after completion, stirring was continued for another 3 hours at room temperature. The solvent was distilled off under reduced pressure to obtain a residue. Acetone was added to this residue, insoluble crystals were filtered off, the insoluble crystals were washed with acetone, the filtrate and the washing solution were combined, and the solvent was distilled off under reduced pressure to obtain 23.3 g of a red oily substance. This oily substance was subjected to silica gel chromatography (solvent: chloroform-methanol).
Purification was performed to obtain 6.3 g (yield 93%) of the title compound.

【0028】mp 108.4〜109.2℃ IRνmax KBrcm-1:3290, 3040, 1625, 1505, 1340, 115
5, 945
Mp 108.4-109.2 ° C IRν max KBr cm -1 : 3290, 3040, 1625, 1505, 1340, 115
5,945

【0029】実施例4 5−(1−t−ブトキシカルボニルアミノ−2−ヒドロ
キシエチル)−1,3,4−オキサジアゾール−2(3
H)−チオンの製造:ジメチルホルムアミド60ml中
に、2−t−ブトキシカルボニルアミノ−3−ヒドロキ
シプロピオノヒドラジド5.0g(23mmol)、トリエ
チルアミン6.9g(68mmol)及び二硫化炭素1.7
g(23mmol)を加え室温で4時間攪拌した。次いで、
反応液中に2−クロロ−1,3−ジメチルイミダゾリニ
ウムクロライド4.6g(27mmol)の塩化メチレン1
6ml溶液をゆっくりと滴下し、終了後室温で更に1時間
攪拌を続けた。反応液にメタノール10mlを加え室温で
放置した後、減圧下溶媒を留去して残渣を得た。以下実
施例3と同様の操作を行ない、標記化合物を4.5g
(収率75%)得た。
Example 4 5- (1-t-Butoxycarbonylamino-2-hydroxyethyl) -1,3,4-oxadiazole-2 (3
Preparation of H) -Thion: 5.0 g (23 mmol) of 2-t-butoxycarbonylamino-3-hydroxypropionohydrazide, 6.9 g (68 mmol) of triethylamine and 1.7 of carbon disulfide in 60 ml of dimethylformamide.
g (23 mmol) was added, and the mixture was stirred at room temperature for 4 hours. Then
2-Chloro-1,3-dimethylimidazolinium chloride 4.6 g (27 mmol) methylene chloride 1 was added to the reaction solution.
A 6 ml solution was slowly added dropwise, and after completion, stirring was continued at room temperature for another hour. After adding 10 ml of methanol to the reaction solution and allowing it to stand at room temperature, the solvent was distilled off under reduced pressure to obtain a residue. Then, the same operation as in Example 3 was carried out to obtain 4.5 g of the title compound.
(Yield 75%) was obtained.

【0030】アモルファス IRνmax KBrcm-1:3300, 1690, 1620, 1500, 1370, 115
5, 1055, 940
Amorphous IR ν max KBr cm −1 : 3300, 1690, 1620, 1500, 1370, 115
5, 1055, 940

【0031】実施例5 5−シクロヘキシル−1,3,4−オキサジアゾール−
2(3H)−チオンの製造:塩化メチレン100ml中に
シクロヘキサンカルボヒドラジド0.78g(5.5mm
ol)、トリエチルアミン1.64g(16.2mmol)及
び二硫化炭素0.42g(5.4mmol)を加え室温で
4.5時間攪拌した。次いで、反応液中に2−クロロ−
1,3−ジメチルイミダゾリニウムクロライド1.10
g(6.5mmol)の塩化メチレン7ml溶液をゆっくりと
滴下し、室温で更に3時間攪拌を続けた。以下実施例1
と同様の処理を行ない。標記化合物を0.59g(収率
58%)得た。
Example 5 5-Cyclohexyl-1,3,4-oxadiazole-
Preparation of 2 (3H) -thione: 0.78 g (5.5 mm) of cyclohexane carbohydrazide in 100 ml of methylene chloride.
ol), 1.64 g (16.2 mmol) of triethylamine and 0.42 g (5.4 mmol) of carbon disulfide were added and stirred at room temperature for 4.5 hours. Then, 2-chloro-
1,3-Dimethylimidazolinium chloride 1.10
A solution of g (6.5 mmol) in 7 ml of methylene chloride was slowly added dropwise, and stirring was continued at room temperature for another 3 hours. Example 1 below
Perform the same processing as. 0.59 g (yield 58%) of the title compound was obtained.

【0032】粘稠油状物 IRνmax neatcm-1:3120, 1615, 1575, 1490, 1450, 116
0, 945
Viscous oil IR ν max neat cm −1 : 3120, 1615, 1575, 1490, 1450, 116
0, 945

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】 モノアシルヒドラジン類に、塩基の存在
下、二硫化炭素を反応せしめ、次いで、次の一般式
(1) 【化1】 〔式中、R1 及びR2 は同一又は異なってそれぞれ低級
アルキル基を示し、Xはハロゲン原子を、nは2又は3
の整数を示す〕で表わされるハロイミニウム塩を反応さ
せることを特徴とする1,3,4−オキサジアゾール−
2(3H)−チオン類の製造法。
1. A monoacylhydrazine is reacted with carbon disulfide in the presence of a base, and then the following general formula (1): [In the formula, R 1 and R 2 are the same or different and each represents a lower alkyl group, X is a halogen atom, and n is 2 or 3
Of 1,3,4-oxadiazole-reacted with a haloiminium salt represented by
Method for producing 2 (3H) -thiones.
JP6047180A 1994-03-17 1994-03-17 Production of 1,3,4-oxadiazole-2(3h)-thione compound Pending JPH07258234A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP6047180A JPH07258234A (en) 1994-03-17 1994-03-17 Production of 1,3,4-oxadiazole-2(3h)-thione compound

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6047180A JPH07258234A (en) 1994-03-17 1994-03-17 Production of 1,3,4-oxadiazole-2(3h)-thione compound

Publications (1)

Publication Number Publication Date
JPH07258234A true JPH07258234A (en) 1995-10-09

Family

ID=12767891

Family Applications (1)

Application Number Title Priority Date Filing Date
JP6047180A Pending JPH07258234A (en) 1994-03-17 1994-03-17 Production of 1,3,4-oxadiazole-2(3h)-thione compound

Country Status (1)

Country Link
JP (1) JPH07258234A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD4118C1 (en) * 2010-09-02 2012-02-29 Институт Химии Академии Наук Молдовы 1,3,4-Oxadiazole compounds containing disubstituted thiourea, manifesting antituberculous properties
MD4125C1 (en) * 2010-09-17 2012-03-31 Inst De Chimie Al Academiei De Stiinte A Moldovei 1,3,4-Oxadiazole compounds with antituberculous properties containing monosubstituted thiourea

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD4118C1 (en) * 2010-09-02 2012-02-29 Институт Химии Академии Наук Молдовы 1,3,4-Oxadiazole compounds containing disubstituted thiourea, manifesting antituberculous properties
MD4125C1 (en) * 2010-09-17 2012-03-31 Inst De Chimie Al Academiei De Stiinte A Moldovei 1,3,4-Oxadiazole compounds with antituberculous properties containing monosubstituted thiourea

Similar Documents

Publication Publication Date Title
WO2004110974A1 (en) Matrix metalloproteinase inhibitors
EP0523244B1 (en) Salt of dithiocarbamic acid, production thereof, and production of isothiocyanate from said salt
JPH07258234A (en) Production of 1,3,4-oxadiazole-2(3h)-thione compound
JP3207018B2 (en) Method for producing benzylsuccinic acid derivative and intermediate for producing the same
JPH06340622A (en) Production of benzylsuccinic acid derivative and intermediate for its synthesis
JPH061776A (en) Production of substituted pyrazinecarbonitrile
JPH0665213A (en) Dicyanopyrazine derivative and its production
JP3046258B2 (en) Method for producing 1-chlorocarbonyl-4-piperidinopiperidine or hydrochloride thereof
JPH0217163A (en) Production of diaminomaleonitrile and diaminoacrylonitrile derivative
JP3038380B1 (en) Method for producing ketene imine compound
JPS5838261A (en) Novel 1,3-disubstituted imidazole derivative and its preparation
JPH0812658A (en) Production of sydnones
US3692793A (en) 2,4-pyridinediyl benzenesulfonates
JP3808931B2 (en) Optically active 4,5-diphenyl-1,3-dialkyl-2-halogenoimidazolinium halogenide
JPH0789924A (en) Production of carbamate compounds
JP3261454B2 (en) Method for producing ketene imine compound
JPS63166867A (en) Production of thioether compounds
JPS62267267A (en) Pyrazole derivative and production thereof
JPS5916879A (en) Production of n-substituted imidazole
JPH0383988A (en) Production of diester compound
JPS5910657B2 (en) Method for producing benzoic acid derivatives
JPH0912558A (en) Method for preparing 1,2,4-triazolium and 1,2,4-triazolinone
JPH06172359A (en) Dicyanopyrrolopyrazine derivative and its production
JPH0827148A (en) Production of dithiazolium salt
JPS6245877B2 (en)